Liren Wang
Impact in
-
- Innovation and Socioeconomic Development
- Aging top 5%
Papers in
-
- CRISPR and Genetic Engineering 18
- Pluripotent Stem Cells Research 5
- Surgery 13
- Tissue Engineering and Regenerative Medicine 8
- Knee injuries and reconstruction techniques 4
- Co-authors
- Dali Li (24 shared papers)Mingyao Liu (16 shared papers)Xianglong Yang (5 shared papers)Yiming Zhou (3 shared papers)Xishan Guo (2 shared papers)Yanjiao Shao (6 shared papers)Yuting Guan (6 shared papers)Ming‐Hua Zheng (18 shared papers)
- Journals
- Oncotarget (6 papers)Science China Life Sciences (4 papers)Medicine (3 papers)Cytotherapy (2 papers)Dermatologic Surgery (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Liren Wang
68 papers receiving 1.9k citations
Liren Wang's Hit Papers
Peers
Comparison fields: 5 of 133
- Business and International Management 82
- Aging 55
- Molecular Biology 927
- Genetics 306
- Hepatology 76
Countries citing papers authored by Liren Wang
This map shows the geographic impact of Liren Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liren Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liren Wang more than expected).
Fields of papers citing papers by Liren Wang
This network shows the impact of papers produced by Liren Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liren Wang. The network helps show where Liren Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liren Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 155 | |
| 2 | 2016 | 133 | |
| 3 | CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia Hit paper breakdown → | 2022 | 119 |
| 4 | 2020 | 99 | |
| 5 | 2007 | 97 | |
| 6 | 2013 | 95 | |
| 7 | 2015 | 77 | |
| 8 | 2007 | 76 | |
| 9 | 2009 | 63 | |
| 10 | 2016 | 55 | |
| 11 | 2023 | 51 | |
| 12 | 2020 | 44 | |
| 13 | 2022 | 43 | |
| 14 | 2018 | 42 | |
| 15 | 2016 | 40 | |
| 16 | 2023 | 40 | |
| 17 | 2010 | 38 | |
| 18 | 2015 | 35 | |
| 19 | 2020 | 35 | |
| 20 | 2022 | 34 |
About Liren Wang
Liren Wang is a scholar working on Molecular Biology, Surgery, Genetics, Biomaterials and Genetics, having authored 70 papers that have together received 2.0k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (18 papers), Tissue Engineering and Regenerative Medicine (8 papers), Electrospun Nanofibers in Biomedical Applications (7 papers), Hemoglobinopathies and Related Disorders (5 papers), Virus-based gene therapy research (5 papers), Pluripotent Stem Cells Research (5 papers), Tendon Structure and Treatment (5 papers) and Knee injuries and reconstruction techniques (4 papers). The work is most often cited by research in Business and International Management (82 citations), Aging (55 citations), Molecular Biology (927 citations), Genetics (306 citations) and Hepatology (76 citations). Liren Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Dali Li, Mingyao Liu, Xianglong Yang, Yiming Zhou, Xishan Guo, Yanjiao Shao, Yuting Guan, Ming‐Hua Zheng, Martin Braddock and Meizhen Liu. Their work appears in journals such as Oncotarget, Science China Life Sciences, Medicine, Cytotherapy and Dermatologic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.